Skip to content

Survival and PN Dependence in SBS Patients

Long-term Survival and Parenteral Nutrition Dependence in Adult Patients With Non-malignant Short Bowel Syndrome

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06102668
Enrollment
173
Registered
2023-10-26
Start date
2012-01-01
Completion date
2019-01-01
Last updated
2023-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Short Bowel Syndrome

Brief summary

Short bowel syndrome (SBS) is a rare condition resulting from the loss of portions of the small intestine, and can cause a spectrum of metabolic and physiologic disturbances.The objective of this study was to determine the longterm survival and parenteral nutrition dependence of adult patients with SBS.

Detailed description

Short bowel syndrome (SBS), the most common form of intestinal failure, is a rare condition resulting from the loss of portions of the intestine, typically because of extensive surgical resection or loss of intestinal function. Patients with SBS often stuffer from intestinal insufficiency or intestinal failure because they are unable to maintain fluid and nutrient balances on a normal diet. SBS can cause various metabolic and physiologic disturbances. Although parenteral nutrition is a life-saving measure for many patients with SBS, patients with SBS is associated with decreased survival and parenteral nutrition (PN) dependence. Few studies have reported the survival and PN dependence in adult SBS patients in China.

Interventions

None listed

Sponsors

Jinling Hospital, China
CollaboratorOTHER
The First Affiliated Hospital of University of Science and Technology of China
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Adult patients diagnosed with SBS.

Exclusion criteria

* age \<18 years; patients with active malignant tumors.

Design outcomes

Primary

MeasureTime frameDescription
Survival2012/1/1-2019/1/1Survival rate in patients with SBS
Parenteral nutrition dependence2012/1/1-2019/1/1Parenteral nutrition dependence in patients with SBS

Secondary

MeasureTime frameDescription
Risk factors2012/1/1-2019/1/1Risk factors of mortality and parenteral dependence in patients with SBS
Cause of death2012/1/1-2019/1/1Cause of death in patients with SBS at the end of follow-up

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026